Skip to main content

Advertisement

SpringerLink
Log in

Management of Lentigo Maligna: Update on Surgical and Medical Treatments

  • Medical Surgery (J Thiele, Section Editor)
  • Published:
Current Dermatology Reports Aims and scope Submit manuscript

Abstract

Lentigo maligna (LM) is the most common subtype of melanoma in situ and is increasing in incidence. It commonly appears as a large pigmented lesion on the head and neck of the older population. Management of LM is guided by the desire to eliminate the tumor completely and prevent recurrence, while maintaining aesthetics of the head/neck region. We summarize the recent literature for surgical and medical treatments of LM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Swetter SM, Boldrick JC, Jung SY, Egbert BM, Harvell JD. Increasing incidence of lentigo maligna melanoma subtypes: northern California and national trends 1990-2000. J Invest Dermatol. 2005;125:685–91.

    Article  CAS  PubMed  Google Scholar 

  2. McGuire LK, Disa JJ, Lee EH, Busam KJ, Nehal KS. Melanoma of the lentigo maligna subtype: diagnostic challenges and current treatment paradigms. Plast Reconstr Surg. 2012;129:288e–99.

    Article  CAS  PubMed  Google Scholar 

  3. Bosbous MW, Dzwierzynski WW, Neuburg M. Lentigo maligna: diagnosis and treatment. Clin Plast Surg. 2010;37:35–46.

    Article  PubMed  Google Scholar 

  4. Erickson C, Miller SJ. Treatment options in melanoma in situ: topical and radiation therapy, excision and Mohs surgery. Int J Dermatol. 2010;49:482–91.

    Article  PubMed  Google Scholar 

  5. Schiffner R, Schiffner-Rohe J, Vogt T, Landthaler M, Wlotzke U, Cognetta AB, et al. Improvement of early recognition of lentigo maligna using dermatoscopy. J Am Acad Dermatol. 2000;42:25–32.

    Article  CAS  PubMed  Google Scholar 

  6. Chuh AA, Wong WC, Wong SY, Lee A. Procedures in primary care dermatology. Aust Fam Physician. 2005;34:347–51.

    PubMed  Google Scholar 

  7. Abdelmalek M, Loosemore MP, Hurt MA, Hruza G. Geometric staged excision for the treatment of lentigo maligna and lentigo maligna melanoma: a long-term experience with literature review. Arch Dermatol. 2012;148:599–604. This is the latest review of geometric staged excision for LM.

    Article  PubMed  Google Scholar 

  8. Hilari H, Llorca D, Traves V, Villanueva A, Serra-Guillen C, Requena C, et al. Conventional surgery compared with slow Mohs micrographic surgery in the treatment of lentigo maligna: a retrospective study of 62 cases. Actas Dermosifiliogr. 2012;103:614–23. Wide local excision with 5mm margins was found to be inadequate by this study.

    Article  CAS  PubMed  Google Scholar 

  9. Dawn ME, Dawn AG, Miller SJ. Mohs surgery for the treatment of melanoma in situ: a review. Dermatol Surg. 2007;33:395–402.

    Article  CAS  PubMed  Google Scholar 

  10. Iorizzo 3rd LJ, Chocron I, Lumbang W, Stasko T. Importance of vertical pathology of debulking specimens during Mohs micrographic surgery for lentigo maligna and melanoma in situ. Dermatol Surg. 2013;39:365–71. This is a study of the percentage of LM upstaged to LMM by histological assessment of tumor debulk.

    Article  CAS  PubMed  Google Scholar 

  11. Kwon SY, Miller SJ. Mohs surgery for melanoma in situ. Dermatol Clin. 2011;29:175–83. vii-viii.

    Article  CAS  PubMed  Google Scholar 

  12. Bichakjian CK, Halpern AC, Johnson TM, Foote Hood A, Grichnik JM, Swetter SM, et al. Guidelines of care for the management of primary cutaneous melanoma. American Academy of Dermatology. J Am Acad Dermatol. 2011;65:1032–47. Guidelines for the management of LM by the AAD stress the importance of SLNB in providing prognostic information.

    Article  PubMed  Google Scholar 

  13. Gaudy-Marqueste C, Perchenet AS, Tasei AM, Madjlessi N, Magalon G, Richard MA, et al. The “spaghetti technique”: an alternative to Mohs surgery or staged surgery for problematic lentiginous melanoma (lentigo maligna and acral lentiginous melanoma). J Am Acad Dermatol. 2011;64:113–8. This is a study of the efficacy of the spaghetti technique for treatment of LM.

    Article  PubMed  Google Scholar 

  14. El Tal AK, Abrou AE, Stiff MA, Mehregan DA. Immunostaining in Mohs micrographic surgery: a review. Dermatol Surg. 2010;36:275–90.

    Article  PubMed  Google Scholar 

  15. Cotter MA, McKenna JK, Bowen GM. Treatment of lentigo maligna with imiquimod before staged excision. Dermatol Surg. 2008;34:147–51.

    Article  CAS  PubMed  Google Scholar 

  16. Ly L, Kelly JW, O’Keefe R, Sutton T, Dowling JP, Swain S, et al. Efficacy of imiquimod cream, 5 %, for lentigo maligna after complete excision: a study of 43 patients. Arch Dermatol. 2011;147:1191–5.

    Article  CAS  PubMed  Google Scholar 

  17. Wong JG, Toole JW, Demers AA, Musto G, Wiseman MC. Topical 5 % imiquimod in the treatment of lentigo maligna. J Cutan Med Surg. 2012;16:245–9.

    CAS  PubMed  Google Scholar 

  18. Hyde MA, Hadley ML, Tristani-Firouzi P, Goldgar D, Bowen GM. A randomized trial of the off-label use of imiquimod, 5%, cream with vs without tazarotene, 0.1%, gel for the treatment of lentigo maligna, followed by conservative staged excisions. Arch Dermatol. 2012;148:592–6. This study compared imiquimod-only with imiquimod + tazarotene as treatments for LM. No significant difference in clearance rates was found.

    Article  CAS  PubMed  Google Scholar 

  19. Fogarty GB, Hong A, Scolyer RA, Lin E, Haydu L, Guitera P, et al. Radiotherapy for lentigo maligna: a literature review and recommendations for treatment. Br J Dermatol. 2014;170:52–8. This is the first review of radiation therapy for LM.

    Article  CAS  PubMed  Google Scholar 

  20. McLeod M, Choudhary S, Giannakakis G, Nouri K. Surgical treatments for lentigo maligna: a review. Dermatol Surg. 2011;37:1210–28.

    Article  CAS  PubMed  Google Scholar 

  21. Coleman 3rd WP, Davis RS, Reed RJ, Krementz ET. Treatment of lentigo maligna and lentigo maligna melanoma. J Dermatol Surg Oncol. 1980;6:476–9.

    PubMed  Google Scholar 

  22. Pitman GH, Kopf AW, Bart RS, Casson PR. Treatment of lentigo maligna and lentigo maligna melanoma. J Dermatol Surg Oncol. 1979;5:727–37.

    CAS  PubMed  Google Scholar 

Download references

Compliance with Ethics Guideline

ᅟ

Conflict of Interest

T.R. Sharma declares no conflicts of interest.

J.S. Bordeaux declares no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. School of Medicine, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, OH, 44106, USA

    Timmie R. Sharma

  2. Department of Dermatology, University Hospitals Case Medical Center, 11100 Euclid Avenue, Lakeside 3500, Cleveland, OH, 44124, USA

    Jeremy S. Bordeaux

Authors
  1. Timmie R. Sharma
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jeremy S. Bordeaux
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jeremy S. Bordeaux.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sharma, T.R., Bordeaux, J.S. Management of Lentigo Maligna: Update on Surgical and Medical Treatments. Curr Derm Rep 3, 86–90 (2014). https://doi.org/10.1007/s13671-014-0072-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13671-014-0072-3

Keywords

Search

Navigation